MRVI
NASDAQ
$6.99
Maravai LifeSciences Holdings Inc - Class A (MRVI)
Maravai LifeSciences Holdings, Inc., a life sciences company, offers products to enable the development of drug therapies, diagnostics, novel vaccines, and to support human disease research in the United States and internationally. The company is headquartered in San Diego, California.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $5.90 (-15.59%)
Market Cap
$451M
Free Cash Flow Yield
-14.69%
Beta (5Y)
1.21
Price Chart
Valuation
Market Cap$451M
Forward P/E370.37
P/S6.02
P/B1.65
Profitability
Total Revenue (TTM)$192M
Gross Profit (TTM)$62M
EBITDA-$171M
Profit Margin-61.4%
Operating Margin-98.6%
EPS-$1.35
Financial Health
Debt-to-Equity119.3%
Free Cash Flow Yield-14.69%
Growth & Risk
Beta (5Y)1.21
Sharpe Ratio1.73